Cabergoline ZPHC — 0.25 mg × 25 tablets contains cabergoline, a long-acting dopamine receptor agonist. It is commonly used to manage elevated prolactin levels and to support endocrine balance.
By stimulating dopamine receptors, cabergoline reduces prolactin secretion from the pituitary gland. This mechanism makes it effective in protocols aimed at controlling prolactin-related conditions.
The 0.25 mg dosage allows flexible adjustment depending on individual needs, while the 25-tablet package ensures a sufficient supply for extended use under professional supervision.
